ES2180699T3 - Agentes antifungicos peptidicos ciclicos. - Google Patents

Agentes antifungicos peptidicos ciclicos.

Info

Publication number
ES2180699T3
ES2180699T3 ES96303625T ES96303625T ES2180699T3 ES 2180699 T3 ES2180699 T3 ES 2180699T3 ES 96303625 T ES96303625 T ES 96303625T ES 96303625 T ES96303625 T ES 96303625T ES 2180699 T3 ES2180699 T3 ES 2180699T3
Authority
ES
Spain
Prior art keywords
sub
sup
antifungic
agents
cyclic peptidic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96303625T
Other languages
English (en)
Inventor
Peter Stanley Borromeo
William Wilson Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2180699T3 publication Critical patent/ES2180699T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PROPORCIONAN FORMULACIONES FARMACEUTICAS Y METODOS PARA LA INHIBICION DE LA ACTIVIDAD FUNGAL Y PARASITARIA UTILIZANDO UN COMPUESTO DE FORMULA I DONDE R'', R", R"'', R{SUP,X1}, R{SUP,X2}, R{SUP,Y1}, R{SUP,Y2}, R{SUP,Y3}, R{SUP,Y4} Y R{SUP,0} SON COMO SE DEFINEN ANTERIORMENTE; R{SUP,2} ES CADA R{SUP,2A} ES INDEPENDIENTEMENTE HIDROXI, HALO, NITRO, AMINO, TRIFLUOMETILO, ALQUILO C{SUB,1}-C{SUB,6}, ALCOXI C{SUB,1}C{SUB,6} O ALQUILTIO C{SUB,1}-C{SUB,6}; A ES 1, 2, 3 O 4; R{SUP,3} ES ALQUILO C{SUB,1}-C{SUB,12}, ALCOXI C{SUB,1}-C{SUB,12} O -O-(CH{SUB,2}){SUB,M}-[O-(CH{SUB,2}){SUB,N}]{SUB,P}-O-(ALQUILO C{SUB,1}-C{SUB,12}); M ES 2, 3 O 4; N ES 2, 3 O 4; Y P ES O O 1; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS
ES96303625T 1995-05-26 1996-05-21 Agentes antifungicos peptidicos ciclicos. Expired - Lifetime ES2180699T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45133795A 1995-05-26 1995-05-26

Publications (1)

Publication Number Publication Date
ES2180699T3 true ES2180699T3 (es) 2003-02-16

Family

ID=23791818

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96303625T Expired - Lifetime ES2180699T3 (es) 1995-05-26 1996-05-21 Agentes antifungicos peptidicos ciclicos.

Country Status (11)

Country Link
US (1) US5786325A (es)
EP (1) EP0744407B1 (es)
AR (1) AR002104A1 (es)
AT (1) ATE225804T1 (es)
AU (1) AU5799096A (es)
DE (1) DE69624167T2 (es)
ES (1) ES2180699T3 (es)
IL (1) IL118331A0 (es)
PE (1) PE37897A1 (es)
WO (1) WO1996037509A1 (es)
ZA (1) ZA964011B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
AU8687798A (en) * 1997-08-04 1999-02-22 Eli Lilly And Company Cyclic peptide antifungal agents
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
PT1137663E (pt) 1998-12-09 2006-12-29 Lilly Co Eli Purificação de compostos ciclopéptidos equinocandina
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
WO2000052037A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin/carbohydrate complexes
CA2362481C (en) * 1999-03-03 2008-11-04 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
CA2362482A1 (en) 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
WO2002062398A2 (en) 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
EP1458416A1 (en) 2001-12-13 2004-09-22 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
US6991800B2 (en) * 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
MXPA05011536A (es) * 2003-04-30 2006-01-23 Inst For Pharm Discovery Inc Acidos carboxilicos substituidos con fenilo como inhibidores de la proteina tirosina fosfatasa-1b.
US10825328B2 (en) 2017-07-03 2020-11-03 Motorola Solutions, Inc. Apparatus for managing a plurality of devices in a portable communication system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320052A (en) * 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293488A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US5166135A (en) * 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
DK173802B1 (da) * 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
CA2037957A1 (en) * 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
IE910892A1 (en) * 1990-03-19 1991-09-25 Merck & Co Inc Lipopeptide compounds
US5330973A (en) * 1990-03-19 1994-07-19 Merck & Co., Inc. Lipopeptide derivatives
IL97347A0 (en) * 1990-03-19 1992-05-25 Merck & Co Inc Lipopeptide derivatives and antimicrobial compositions containing them
US5310726A (en) * 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5386009A (en) * 1990-03-19 1995-01-31 Merck & Co. Inc. Lipopeptide derivatives
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
US5233023A (en) * 1991-07-30 1993-08-03 Merck & Co., Inc. Process for phosphate ester compounds of certain cyclohexapeptides
CZ288974B6 (cs) * 1992-03-19 2001-10-17 Eli Lilly And Company Acylový derivát echinocandinu, způsob jeho přípravy, farmaceutický prostředek s jeho obsahem a jeho pouľití
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US5948753A (en) * 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
CA2161149A1 (en) * 1993-05-04 1994-11-10 James M. Balkovec Cyclohexapeptidyl aminoalkyl ethers
US5541160A (en) * 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) * 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) * 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
DE69624167T2 (de) 2003-02-13
ZA964011B (en) 1997-11-20
IL118331A0 (en) 1996-09-12
PE37897A1 (es) 1997-10-09
EP0744407B1 (en) 2002-10-09
EP0744407A2 (en) 1996-11-27
US5786325A (en) 1998-07-28
AR002104A1 (es) 1998-01-07
DE69624167D1 (de) 2002-11-14
WO1996037509A1 (en) 1996-11-28
ATE225804T1 (de) 2002-10-15
AU5799096A (en) 1996-12-11
EP0744407A3 (en) 1998-05-20

Similar Documents

Publication Publication Date Title
ES2180699T3 (es) Agentes antifungicos peptidicos ciclicos.
MY136593A (en) Cyclic peptide antifungal agents and process for preparation thereof
ES2187617T3 (es) Agentes antifungicos de hexapeptidos ciclicos.
TR200102038T2 (tr) Amid bileşenler
FR2757522B1 (fr) Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
ES2188722T3 (es) Agentes antifungicos peptidicos ciclicos.
ATE245435T1 (de) Totalsynthese des amino hip analogen von didemnin a
ES2002053A6 (es) Procedimiento para la obtencion de peptidos inihiobidores de renina que contienen grupos hidroxi.
ES2133295T3 (es) Peptidos ciclicos y su uso.
DE69434652D1 (de) Antikonvulsive pseudofructopyranose sulfamate
ATE253359T1 (de) Antithrombotische mittel
HUP0203275A2 (hu) 1-(Gyűrűs amino)-alkilciklohexán-származékok, ezeket tartalmazó görcsoldó hatású gyógyszerkészítmények, valamint ezek alkalmazása
EP0744406A3 (en) Cyclic peptide antifungal agents
DK1107981T3 (da) Syntese af ringmodificerede, cykliske peptidanaloger
HUP9904659A2 (hu) Aril-karbonsav- és tetrazolszármazékok, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények
NO308658B1 (no) Sammenføyde isoquinoliner som dopamin-reseptor-ligander
FR2767526B1 (fr) Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant
ES2117678T3 (es) Derivados de eteres milbemicina, su preparacion y su aplicacion terapeutica y agroquimica.
AR027578A1 (es) Derivados de indano
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
DE69828522D1 (de) Antithrombotische mittel
FR2766489B1 (fr) Derives de streptogramines, leur preparation et les compositions qui les contiennent
DE59601875D1 (de) 2-phasen-haarbehandlungsmittel
FR2766487B1 (fr) Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant
NO20004613L (no) FremgangsmÕte for fremstilling av et tetrapeptid